EQUITEST— 510(k) K851744

Substantially Equivalent

Neurocom International, Inc.

FDA 510(k) clearance K851744 for EQUITEST, Substantially Equivalent on 1985-08-05. Applicant: Neurocom International, Inc..

Clearance details

Applicant
Neurocom International, Inc.
Product code
Code LXV
Advisory panel
Unknown
Date received
Decision date
Decision
Substantially Equivalent
Clearance type
Traditional
Location
Portland, OR, US
Download summary PDFView on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.